Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.

Source:http://linkedlifedata.com/resource/pubmed/id/16821771

J. Med. Chem. 2006 Jul 13 49 14 4098-115

Download in:

View as

General Info

PMID
16821771